Kang Cheng
Papers
1
Total Citations
2
H-Index
1
About
Dr. Kang Cheng is a distinguished urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal cell carcinoma (RCC). His primary research focus lies in optimizing robot-assisted partial nephrectomy (RAPN), with a particular emphasis on comparing transperitoneal and retroperitoneal approaches to improve patient outcomes. In his landmark 2024 study, Dr. Cheng conducted a retrospective cohort analysis at the Affiliated Hospital of Jiangsu University, systematically evaluating the perioperative and functional effects of these two surgical routes. This work provides critical evidence for tailoring surgical strategies in RCC patients, directly influencing clinical decision-making to reduce complications and preserve renal function. While his most-cited paper has garnered 2 citations to date, its recent publication underscores the emerging impact of his contributions. Dr. Cheng’s research bridges the gap between surgical innovation and patient-centered care, offering actionable insights for urologists worldwide. His dedication to refining robotic techniques positions him as a rising authority in urologic oncology, with future studies likely to further shape best practices in nephron-sparing surgery.
Research Focus
Key Achievements
Top Papers
- 1